🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Open label multicentric randomized phase II trial, using high throughput ge...
Status
Completed
Location
Centre Hospitalier Henri Duffau
Start Date
2014-04-23
Trial ID
NCT02117167
The primary purpose of the study is to assess the safety, tolerability and ...
Status
Active Not Recruiting
Location
Research Site
Start Date
2007-03-08
Trial ID
NCT00463814
Treatments Being Tested
Background: \- The current standard of care for advanced lung cancer and c...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2011-02-08
Trial ID
NCT01306045
Study to assess the effect of Selumetinib \[AZD6244; ARRY-142886\] \[Hyd-Su...
Status
Completed
Location
Research Site
Start Date
2014-03
Trial ID
NCT02056392
Treatments Being Tested
Phase 2 Platform Study in Patients with Advanced Non-Small Lung Cancer who ...
Status
Active Not Recruiting
Location
Research Site
Start Date
2019-06-25
Trial ID
NCT03944772
This is a phase I, open-label, dose-escalation study to determine the MTD o...
Status
Recruiting
Location
The University of Chicago
Start Date
2018-09-04
Trial ID
NCT03326310
Treatments Being Tested
This is a multicenter, worldwide, open-label study of MK-8353 in combinatio...
Status
Completed
Location
Florida Cancer Specialists ( Site 7000)
Start Date
2019-02-22
Trial ID
NCT03745989
Treatments Being Tested
Study to assess the effect of Rifampicin on the pharmacokinetics of Selumet...
Status
Completed
Location
Research Site
Start Date
2014-02
Trial ID
NCT02046850
Treatments Being Tested
The objective of this study will be to investigate the safety and tolerabil...
Status
Completed
Location
Research Site
Start Date
2012-06
Trial ID
NCT01605916
Treatments Being Tested
The purpose of this study is to assess the efficacy of selumetinib in combi...
Status
Active Not Recruiting
Location
Research Site
Start Date
2013-09-25
Trial ID
NCT01933932
Treatments Being Tested